People in the News | GenomeWeb

People in the News

Premium

Frank Witney has been named chief commercial officer at Affymetrix. As CCO, Witney is charged with integrating the commercial teams of Affy and its recently acquired companies, Panomics, True Materials, and USB.

Witney joined Panomics, formerly Genospectra, as CEO in 2002. Prior to that, he served as president of drug discovery tools at PerkinElmer Life sciences.

Witney was a postdoc fellow at the National Institutes of Health and holds a PhD in molecular and cell biology from Indiana University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.